Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis

Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis

Bibliographic Details
Main Authors: Marta Consuegra-Fernández, Marcos Isamat, Francisco Lozano
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Immunology
Subjects:
CD6
multiple sclerosis
itolizumab
UMCD6
experimental autoimmune encephalomyelitis
collagen-induced arthritis
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01217/full
id doaj-03c429206caf4e23a262dd485b07a370
record_format Article
spelling doaj-03c429206caf4e23a262dd485b07a3702020-11-24T23:40:05ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-09-01810.3389/fimmu.2017.01217290005Commentary: CD6 As a Potential Target for Treating Multiple SclerosisMarta Consuegra-Fernández0Marcos Isamat1Francisco Lozano2Francisco Lozano3Francisco Lozano4Immunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, SpainImmunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, SpainImmunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, SpainServei d’Immunologia, Centre de Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, SpainDepartament de Biomedicina, Universitat de Barcelona, Barcelona, Spainhttp://journal.frontiersin.org/article/10.3389/fimmu.2017.01217/fullCD6multiple sclerosisitolizumabUMCD6experimental autoimmune encephalomyelitiscollagen-induced arthritis
collection DOAJ
language English
format Article
sources DOAJ
author Marta Consuegra-Fernández
Marcos Isamat
Francisco Lozano
Francisco Lozano
Francisco Lozano
spellingShingle Marta Consuegra-Fernández
Marcos Isamat
Francisco Lozano
Francisco Lozano
Francisco Lozano
Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
Frontiers in Immunology
CD6
multiple sclerosis
itolizumab
UMCD6
experimental autoimmune encephalomyelitis
collagen-induced arthritis
author_facet Marta Consuegra-Fernández
Marcos Isamat
Francisco Lozano
Francisco Lozano
Francisco Lozano
author_sort Marta Consuegra-Fernández
title Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
title_short Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
title_full Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
title_fullStr Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
title_full_unstemmed Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
title_sort commentary: cd6 as a potential target for treating multiple sclerosis
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2017-09-01
topic CD6
multiple sclerosis
itolizumab
UMCD6
experimental autoimmune encephalomyelitis
collagen-induced arthritis
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01217/full
work_keys_str_mv AT martaconsuegrafernandez commentarycd6asapotentialtargetfortreatingmultiplesclerosis
AT marcosisamat commentarycd6asapotentialtargetfortreatingmultiplesclerosis
AT franciscolozano commentarycd6asapotentialtargetfortreatingmultiplesclerosis
AT franciscolozano commentarycd6asapotentialtargetfortreatingmultiplesclerosis
AT franciscolozano commentarycd6asapotentialtargetfortreatingmultiplesclerosis
_version_ 1725511115433050112

Similar Items